PATENT CLAIM ANALYSIS

Application Number: 15747604
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "277000"]

Abstract:
It is an object of the present invention to provide a pharmaceutical composition which can suppress a reduction in the content of an active ingredient caused by oxidation or decomposition of the rapamycin or a derivative thereof, can ensure long-term stability, and has high safety. The present invention provides a pharmaceutical composition comprising (A) rapamycin or a derivative thereof and (B) trehalose, and a method for producing a pharmaceutical composition comprising rapamycin or a derivative thereof, which comprises adding a solution containing rapamycin or a derivative thereof to sugars having a critical relative humidity at 25° C. of 95% or more.

Claim (Index 5):
The pharmaceutical composition according to  claim 1 , which comprises a cellulose derivative and/or sugars.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 86.0
- Lexical Diversity: 1.75
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15305143', '15569682', '13223207', '13172038', '13073677']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7580173495361502
- 35 USC 102 Novelty (BERT): 0.467844392030078
- Combined Prediction Score: 0.729000053785543
- Mean Citation Score: 152.724142
- Max Citation Score: 161.23492
- Similarity Product: 126.02261633709428

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test